Result of steroid irrigation post-operative sino-nasal skull base tumor surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171030001

Enrollment

Registered

2017-10-30

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative endoscopic sino&#45

Interventions

Budesonide 2mg in NSS 1&#44

000ml irrigation to nasal cavity post&#45

operatively&#44

250ml /side&#44

bid,NSS 1&#44

bid

Experimental Drug,Placebo Comparator Drug

Budesonide irrigation,NSS irrigation

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patient with sino-nasal skull base tumor with biopsy prooved 2. Undergone endoscopic surgery at Ramathibodi hospital 3.Age 18-55 years 4. patient has been inform about the study protocol and give consent.

Exclusion criteria

Exclusion criteria: 1. Active sinus infection before surgery 2. Cannot follow up for 6 month 3. Cannot regularly use the studied medication 4. Has been surgery at sino-nasal prior to current surgery 5 Chronic sinusitis or other disease that affect to wound healing such as DM, Chronic kidney disease, Cancer that received chemotherapy, current steroid user 6. Patient deny to consent

Design outcomes

Primary

Measure	Time frame
Symptoms score 1 week, 1month, 3month, 6month SNOT 22	—

Secondary

Measure	Time frame
Symptoms score 1 week, 1month, 3month, 6month VAS	—

Countries

Thailand

Contacts

Public ContactPoj Pinyopornpanish

Ramathibodi hospital

pojpinyo@hotmail.com66-899549797

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Result of steroid irrigation post&#45;operative sino&#45;nasal skull base tumor surgery